Technical Analysis for NVIV - InVivo Therapeutics Holdings Corp.

Grade Last Price % Change Price Change
grade F 0.48 -3.79% -0.02
NVIV closed down 3.79 percent on Thursday, October 17, 2019, on 1.3 times normal volume.

Earnings due: Nov 7

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical NVIV trend table...

Date Alert Name Type % Chg
Lower Bollinger Band Touch Weakness 0.00%
MACD Bullish Signal Line Cross Bullish -3.79%
Lower Bollinger Band Touch Weakness -3.79%
Hammer Candlestick Bullish -2.04%
Lizard Bullish Bullish Day Trade Setup -2.04%
Lower Bollinger Band Touch Weakness -2.04%
New Downtrend Bearish -4.00%
Pocket Pivot Bullish Swing Setup -4.00%
Narrow Range Bar Range Contraction -4.00%
NR7 Range Contraction -4.00%

Older signals for NVIV ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Invivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, focuses on developing and commercializing technologies for the treatment of spinal cord injury (SCI). The company is developing a Neuro-Spinal Scaffold, an investigational bioresorbable polymer scaffold for the implantation at the site of injury within a spinal cord contusion; and biocompatible Neuro-Spinal Scaffold Plus Stem Cells to treat chronic SCI. Its proprietary technologies incorporate intellectual property licensed under exclusive, worldwide license from Boston Children's Hospital and the Massachusetts Institute of Technology, as well as intellectual property that has been developed internally in collaboration with advisors and partners. The company was founded in 2005 and is based in Cambridge, Massachusetts.
Biotechnology Organ Systems Stem Cells Nervous System Injury Biomaterials Injuries Medical Emergencies Spinal Cord Injury Neurotrauma
Is NVIV a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 2.75
52 Week Low 0.45
Average Volume 20,808
200-Day Moving Average 1.0654
50-Day Moving Average 0.5739
20-Day Moving Average 0.5106
10-Day Moving Average 0.4949
Average True Range 0.0483
ADX 29.87
+DI 7.5248
-DI 22.0856
Chandelier Exit (Long, 3 ATRs ) 0.472
Chandelier Exit (Short, 3 ATRs ) 0.5949
Upper Bollinger Band 0.5608
Lower Bollinger Band 0.4604
Percent B (%b) 0.2
BandWidth 19.663141
MACD Line -0.0285
MACD Signal Line -0.0295
MACD Histogram 0.001
Fundamentals Value
Market Cap 15.45 Million
Num Shares 32.2 Million
EPS -0.76
Price-to-Earnings (P/E) Ratio -0.63
Price-to-Sales 0.00
Price-to-Book 2.29
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.53
Resistance 3 (R3) 0.52 0.50 0.52
Resistance 2 (R2) 0.50 0.49 0.50 0.51
Resistance 1 (R1) 0.49 0.48 0.50 0.50 0.51
Pivot Point 0.47 0.47 0.47 0.47 0.47
Support 1 (S1) 0.46 0.46 0.47 0.47 0.45
Support 2 (S2) 0.44 0.45 0.44 0.45
Support 3 (S3) 0.43 0.44 0.44
Support 4 (S4) 0.44